Search results
ALAMO GROUP ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER OF 2024
Hometownsource.com· 6 days agoSEGUIN, Texas, May 2, 2024 /PRNewswire/ -- Alamo Group Inc. (NYSE: ALG) today reported results for the first quarter ended March 31, 2024.
TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk...
The Missourian· 5 days agoNew data from Phase 2b SunRISe-1 study show rapid achievement of complete response (CR) with 98% achieving a CR within 12 weeks
Lady Panthers fall in single-game area playoff
Brenham Banner-Press· 2 days agoMUMFORD – Getting out of the second round of the Conference 2A softball playoffs was not in the cards for the Burton Lady Panthers, who saw a promising...
Heidrick & Struggles Reports First Quarter 2024 Results
Brenham Banner-Press· 2 days agoQuarterly Revenue of $265 Million, 11% Year Over Year Growth
Rethink How You Fire Up the Grill
Brenham Banner-Press· 6 days ago(Culinary.net) When you think about summer foods and outdoor gatherings, one of the first things that often comes to mind is, of course, grilling. It’s...
ECD Auto Design Announces Full Year 2023 Financial Results
The Daily Reflector· 5 days ago2023 Revenue increased 22.5% compared to 2022
Miami Beach Prepares to Welcome Returning Events and Debut Experiences in May
Henry Daily Herald· 5 days agoMiami Beach is set to host a variety of returning and new events in May, all developed to bring the...
Miami Beach Prepares to Welcome Returning Events and Debut Experiences in May
The Rogersville Review· 5 days agoMiami Beach is set to host a variety of returning and new events in May, all developed to bring the...
22C and Friends of Uplift Enter into Uptown Sustainability Partnership for Students
Leader-Telegram· 6 days agoCHICAGO, May 2, 2024 /PRNewswire/ -- 22C DEVELOPMENT LLC ("22C"), an Illinois community solar company, and Friends of Uplift a 501(c)(3) nonprofit ("FOU") associated with Uplift Community High ...
TAR-210 results show 90% recurrence-free survival and 90% complete response in patients with...
Leader-Telegram· 3 days agoJohnson & Johnson announced today updated results from an open-label, multicenter, multi-cohort Phase 1 study of the safety and efficacy of TAR-210, an intravesical targeted releasing system ...
